Compare Illumina, Inc. (ILMN) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Trip.com Group Ltd — how do they compare? Illumina, Inc. trades at $278.09 (market cap $39.95B), while Trip.com Group Ltd trades at $38.91 (market cap $23.75B). The key difference: Illumina, Inc. is the larger of the two by market cap, and Trip.com Group Ltd pays a 0.42% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Trip.com Group Ltd for 79 Days on average.
| ILMN | TCOM | |
|---|---|---|
Market Cap | $39.95B | $23.75B |
Volume | 3,169,503 | 2,089,737 |
Sector | Health | Consumer Cyclical |
52-Week High | $293.69 | $78.96 |
52-Week Low | $91.00 | $37.96 |
Typical Hold Time | 83 Days | 79 Days |
Enterprise Value | $41.31B | $15.91B |
Dividend Yield | — | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $278.17, up 3.89% today and near its 52-week high of $278.99. The stock shows strong technical momentum with bullish moving averages and has beaten earnings estimates for three consecutive quarters. Recent inclusion in the S&P 500 and positive analyst upgrades reflect growing institutional confidence. Revenue remains stable at $4.34B for 2025 with improved profitability, delivering $850M net income after previous losses.
The outlook remains positive with sequencing growth and AI initiatives driving momentum, though elevated valuation ratios and China market headwinds present risks. Analyst consensus leans bullish with 54% buy ratings, but the current price exceeds the $241 consensus target, suggesting near-term consolidation potential before further upside.
Trip.com (TCOM) trades at $38.90, up 2.13% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $1.07, beating expectations, with revenue growth of 6% year-over-year. Valuation metrics appear attractive with P/E of 7.34 and P/S of 2.6, while maintaining robust profitability with 36.9% net income margin and 15.74% ROE.
Despite regulatory headwinds from recent antitrust penalties, Trip.com's international expansion and strong cash flow generation support long-term growth. The stock faces near-term technical pressure but offers fundamental value with 45.6% upside to the $56.64 consensus price target. Key risks include regulatory scrutiny and competitive pressures in the travel sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
